Fingolimod induced fulminant liver failure requiring liver transplantation: A case report.
Hepatol Forum
; 4(2): 74-77, 2023 Mar.
Article
em En
| MEDLINE
| ID: mdl-37250929
ABSTRACT
Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Hepatol Forum
Ano de publicação:
2023
Tipo de documento:
Article